These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 31039163)
1. Modulation of ADAR mRNA expression in patients with congenital heart defects. Altaf F; Vesely C; Sheikh AM; Munir R; Shah STA; Tariq A PLoS One; 2019; 14(4):e0200968. PubMed ID: 31039163 [TBL] [Abstract][Full Text] [Related]
2. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing. Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663 [TBL] [Abstract][Full Text] [Related]
3. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma. Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of adenosine deaminase acting on RNA 1 in chordoma tissues is associated with chordoma pathogenesis by reducing miR‑125a and miR‑10a expression. Kuang L; Lv G; Wang B; Li L; Dai Y; Li Y Mol Med Rep; 2015 Jul; 12(1):93-8. PubMed ID: 25673044 [TBL] [Abstract][Full Text] [Related]
5. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2. Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133 [TBL] [Abstract][Full Text] [Related]
15. The Role of ADAR1 and ADAR2 in the Regulation of miRNA-21 in Idiopathic Pulmonary Fibrosis. Díaz-Piña G; Ordoñez-Razo RM; Montes E; Páramo I; Becerril C; Salgado A; Santibañez-Salgado JA; Maldonado M; Ruiz V Lung; 2018 Aug; 196(4):393-400. PubMed ID: 29637273 [TBL] [Abstract][Full Text] [Related]
16. RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2. Yamashita T; Tadami C; Nishimoto Y; Hideyama T; Kimura D; Suzuki T; Kwak S Neurosci Res; 2012 May; 73(1):42-8. PubMed ID: 22366356 [TBL] [Abstract][Full Text] [Related]
17. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma. Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440 [TBL] [Abstract][Full Text] [Related]
18. ADAR1- and ADAR2-mediated regulation of maturation and targeting of miR-376b to modulate GABA neurotransmitter catabolism. Widmark A; Sagredo EA; Karlström V; Behm M; Biryukova I; Friedländer MR; Daniel C; Öhman M J Biol Chem; 2022 Mar; 298(3):101682. PubMed ID: 35124003 [TBL] [Abstract][Full Text] [Related]
19. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Yang W; Chendrimada TP; Wang Q; Higuchi M; Seeburg PH; Shiekhattar R; Nishikura K Nat Struct Mol Biol; 2006 Jan; 13(1):13-21. PubMed ID: 16369484 [TBL] [Abstract][Full Text] [Related]
20. ADAR1 and ADAR2 expression and editing activity during forebrain development. Jacobs MM; Fogg RL; Emeson RB; Stanwood GD Dev Neurosci; 2009; 31(3):223-37. PubMed ID: 19325227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]